13 Nov 2020 --- Cargill is set to partner with BioGaia for digestive and immune health following a US$25 million investment. The anchor investment gives Cargill an initial minority stake in the Sweden-based company and was part of BioGaia’s directed issue of 2.86 million class B shares, raising proceeds of SEK 1.1 billion (US$127 million).
